1. Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signaling
   Kang Zhu et al, 2021, FEBS Open Bio CrossRef
2. Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population
   Dong Hang et al, 2016, Virology CrossRef
3. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis
   Loretah Chibaya et al, 2021, Proceedings of the National Academy of Sciences CrossRef
4. Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015–2021 and the genetic variability of HPV16 and 52
   Xiuli Wang et al, 2022, Virology Journal CrossRef
5. REST/NRSF Silencing Modifies Neuronal Gene Expression in siRNA-Treated HeLa Cells: A Preliminary Exploration in the Search for Neuronal Biomarkers of Cervical Cancer
   Karen Cortés-Sarabia et al, 2023, Medicina CrossRef
6. Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage
   Yulan Cheng et al, 2015, PLOS ONE CrossRef
7. Current Perspectives in Human Papilloma Virus: Where We are and What We Need?
   B.S Anjali Devi et al, 2019, Biomedical and Pharmacology Journal CrossRef
8. Benzothiazole derivative bearing amide moiety induces p53-mediated apoptosis in HPV16 positive cervical cancer cells
   Arusha Modi et al, 2020, Investigational New Drugs CrossRef
9. Metabolic Reprogramming in Cancer: Role of HPV 16 Variants
   Adán Arizmendi-Izazaga et al, 2021, Pathogens CrossRef
10. Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer
    Sung Wan Kang et al, 2024, PLOS ONE CrossRef
11. Activities of E6 Protein of Human Papillomavirus 16 Asian Variant on miR-21 Up-regulation and Expression of Human Immune Response Genes
    Peechanika Chopjitt et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
12. Mucosal human papillomavirus detection and TP53 immunohistochemical expression in non‐melanoma skin cancer in Tunisian patients
    Ines Ben Ayed et al, 2019, Journal of Cutaneous Pathology CrossRef
13. Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
    Sergiu Chira et al, 2022, Cells CrossRef
14. The Performance of Minicircle DNA Versus Parental Plasmid in p53 Gene Delivery Into HPV-18-Infected Cervical Cancer Cells
    Dalinda Eusébio et al, 2021, Nucleic Acid Therapeutics CrossRef
15. Panchvalkala, a traditional Ayurvedic formulation, exhibits antineoplastic and immunomodulatory activity in cervical cancer cells and C57BL/6 mouse papilloma model
    Shama Aphale et al, 2021, Journal of Ethnopharmacology CrossRef
16. Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis
    Jayne Knoff et al, 2014, Current Obstetrics and Gynecology Reports CrossRef
17. Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women
    Khaoula HADAMI et al, 2021, Gene CrossRef